Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease

View source ↗

Summary

A clinical trial is evaluating blood-based assays for rapid detection of beta-amyloid pathology in Alzheimer's disease and is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Alzheimer's Disease Diagnosis | Status: ENROLLING_BY_INVITATION